InnovAge Holdings, Inc. INNV Production and delivery
Production and delivery at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by InnovAge Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DirectOperatingCosts.
The official record: InnovAge Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about InnovAge Holdings, Inc.'s production and delivery.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is InnovAge Holdings, Inc.'s production and delivery?
- InnovAge Holdings, Inc. (INNV) reported production and delivery of $77.68M in Q1 2026.
- How has InnovAge Holdings, Inc.'s production and delivery changed year-over-year?
- InnovAge Holdings, Inc.'s production and delivery increased by 11.8% year-over-year, from $69.5M to $77.68M.
- What is the long-term trend for InnovAge Holdings, Inc.'s production and delivery?
- Over 4 years (2021 to 2025), InnovAge Holdings, Inc.'s production and delivery has grown at a 14.9% compound annual growth rate (CAGR), from $154.4M to $268.91M.
- What does production and delivery mean?
- This represents the direct costs incurred to deliver healthcare services to patients, excluding depreciation and amortization. It encompasses the essential expenses required to maintain the company's care delivery model, such as clinical staffing and direct patient support. This metric is a primary indicator of the operational efficiency and direct cost management of the company's core service offerings.